{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:13:13Z","timestamp":1648548793553},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1007\/s11940-999-0022-8","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T13:43:11Z","timestamp":1180964591000},"page":"323-337","source":"Crossref","is-referenced-by-count":2,"title":["Complex partial seizures in adults"],"prefix":"10.1007","volume":"1","author":[{"given":"Michael D.","family":"Privitera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy P.","family":"Szaflarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"22_CR1","volume-title":"Epilepsy: Frequency, Causes and Consequences","author":"WA Hauser","year":"1990","unstructured":"Hauser WA, Hesdorffer DC: Epilepsy: Frequency, Causes and Consequences. New York: Demos; 1990. This entire textbook is an excellent source of information about the epidemiologic aspects of epilepsy."},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","volume":"22","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489\u2013501.","journal-title":"Epilepsia"},{"key":"22_CR3","first-page":"87","volume-title":"Epilepsy: A Comprehensive Textbook","author":"WA Hauser","year":"1997","unstructured":"Hauser WA, Annegers JF: Epidemiology of acute symptomatic seizures. In Epilepsy: A Comprehensive Textbook. Edited by Engel J, Pedley TA. Philadelphia: Lippincott-Raven; 1997:87\u201391."},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1212\/WNL.43.3_Part_1.478","volume":"43","author":"First Seizure Trial Group","year":"1993","unstructured":"First Seizure Trial Group: Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993, 43:478\u2013483. This randomized clinical trial compares the efficacy and adverse effects of antiepileptic drug treatment with those of no treatment for new-onset seizures.","journal-title":"Neurology"},{"key":"22_CR5","first-page":"69","volume-title":"Epilepsy: A Comprehensive Textbook","author":"JWAS Sander","year":"1997","unstructured":"Sander JWAS, Sillanp\u00e4\u00e4 M: Natural history and prognosis. In Epilepsy: A Comprehensive Textbook. Edited by Engel J, Pedley TA. Philadelphia: Lippincott-Raven; 1997:69\u201386."},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.46.1.49","volume":"46","author":"LJ Wilmore","year":"1996","unstructured":"Wilmore LJ, Shu V, Wallin B, et al.: Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. Neurology 1996, 46:49\u201353.","journal-title":"Neurology"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","volume":"313","author":"RH Mattson","year":"1985","unstructured":"Mattson RH, Cramer JA, Collins JF, et al.: Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med 1985, 313:145\u2013151. This superb randomized study compared the four antiepileptic drugs most commonly used at the time. The design set a standard for future comparison studies.","journal-title":"N Engl J Med"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1212\/WNL.27.6.511","volume":"27","author":"A Troupin","year":"1977","unstructured":"Troupin A, Ojemann LM, Halpern L, et al.: Carbamazepine \u2014a double-blind comparison with phenytoin. Neurology 1977, 27:511\u2013519.","journal-title":"Neurology"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archneur.1979.00500370052010","volume":"36","author":"M Kosteljanetz","year":"1979","unstructured":"Kosteljanetz M, Christiansen J, Mouritzen A, et al.: Carbamazepine vs. phenytoin. A controlled clinical trial in focal motor and generalized epilepsy. Arch Neurol 1979, 36:22\u201324.","journal-title":"Arch Neurol"},{"key":"22_CR10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/WNL.33.7.904","volume":"33","author":"RE Ramsay","year":"1983","unstructured":"Ramsay RE, Wilder BJ, Berger JR, et al.: A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology 1983, 33:904\u2013910.","journal-title":"Neurology"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","volume":"327","author":"RH Mattson","year":"1992","unstructured":"Mattson RH, Cramer JA, Collins JF, et al.: A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clinic seizures in adults. N Engl J Med 1992, 327:765\u2013771. This was a follow-up to the study published in 1985 [7].","journal-title":"N Engl J Med"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","volume":"345","author":"MJ Brodie","year":"1995","unstructured":"Brodie MJ, Richens A, Yuen AWC: Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995, 345:476\u2013479. This important study was the first to compare a drug from the new generation of antiepileptic drugs with carbamazepine, one of the standard antiepileptic drugs. Lamotrigine was as effective as carbamazepine and had fewer adverse effects.","journal-title":"Lancet"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1212\/WNL.49.3.739","volume":"49","author":"GK Bergey","year":"1997","unstructured":"Bergey GK, Morris HH, Rosenfeld W, et al.: Gabapentin monotherapy: I. An 8 day, double-blind, dosecontrolled, multicenter study in hospitalized patients with refractory complex partial or secondary generalized seizures. Neurology 1997, 49:739\u2013745.","journal-title":"Neurology"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1212\/WNL.31.10.1271","volume":"31","author":"AJ Wilensky","year":"1981","unstructured":"Wilensky AJ, Ojemann LM, Temkin NR, et al.: Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study. Neurology 1981, 31:1271\u20131276.","journal-title":"Neurology"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.48.1.182","volume":"48","author":"A Beydoun","year":"1997","unstructured":"Beydoun A, Sackellares JC, Shu V, et al.: Safety and efficacy of divalproex sodium monotherapy in partial seizures. A double-blind, concentration-response design clinical trial. Neurology 1997, 48:182\u2013188.","journal-title":"Neurology"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1212\/WNL.49.3.746","volume":"49","author":"A Beydoun","year":"1997","unstructured":"Beydoun A, Fischer J, Labar DR, et al.: Gabapentin monotherapy: II. A 26-week, double-blind, dose controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondary generalized seizures. Neurology 1997, 49:746\u2013752.","journal-title":"Neurology"},{"key":"22_CR17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.51.4.1018","volume":"51","author":"F Gilliam","year":"1998","unstructured":"Gilliam F, Vazquez B, Sackellares JC, et al.: An activecontrol trial of lamotrigine monotherapy for partial seizures. Neurology 1998, 51:1018\u20131025.","journal-title":"Neurology"},{"key":"22_CR18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1528-1157.1997.tb01120.x","volume":"38","author":"RC Sachdeo","year":"1997","unstructured":"Sachdeo RC, Reife RA, Lim P, et al.: Topiramate monotherapy for partial onset seizures. Epilepsia 1997, 38:294\u2013300.","journal-title":"Epilepsia"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410320313","volume":"32","author":"R Sachdeo","year":"1992","unstructured":"Sachdeo R, Kramer LD, Rosenberg A, et al.: Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 1992, 32:386\u2013392.","journal-title":"Ann Neurol"},{"key":"22_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0920-1211(94)00084-A","volume":"20","author":"O Devinsky","year":"1995","unstructured":"Devinsky O, Faught RE, Wilder BJ, et al.: Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Res 1995, 20:241\u2013246.","journal-title":"Epilepsy Res"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.43.4.688","volume":"42","author":"E Faught","year":"1993","unstructured":"Faught E, Sachdeo RC, Remler MP, et al.: Felbamate monotherapy for partial-onset seizures: an activecontrol trial. Neurology 1993, 42:688\u2013692.","journal-title":"Neurology"},{"key":"22_CR22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJM198809153191102","volume":"319","author":"SKC Ng","year":"1988","unstructured":"Ng SKC, Hauser WA, Brust JCM, et al.: Alcohol consumption and withdrawal in new-onset seizures. N Engl J Med 1988, 319:666\u2013673.","journal-title":"N Engl J Med"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/jnnp.49.12.1386","volume":"49","author":"P Wolf","year":"1986","unstructured":"Wolf P, Goosses R: Relation of photosensitivity to epileptic syndromes. J Neurol Neurosurg Psychiatry 1986, 49:1386\u20131391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22_CR24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/106002809302701001","volume":"27","author":"MD Privitera","year":"1993","unstructured":"Privitera MD: Clinical rules for phenytoin dosing. Ann Pharmacother 1993, 27:1169\u20131172.","journal-title":"Ann Pharmacother"},{"key":"22_CR25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1345\/aph.17332","volume":"32","author":"GD Anderson","year":"1998","unstructured":"Anderson GD: A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother 1998, 32:554\u2013563. This review provides a useful guide to the P450 subenzyme systems and a practical method for predicting drug interactions.","journal-title":"Ann Pharmacother"},{"key":"22_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00007691-198810010-00009","volume":"10","author":"M Levine","year":"1988","unstructured":"Levine M, McCollom RM, Chang T, et al.: Evaluation of serum phenytoin monitoring in an acute care setting. Ther Drug Monit 1988, 10:50\u201357.","journal-title":"Ther Drug Monit"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jnnp.58.1.44","volume":"58","author":"AJ Heller","year":"1995","unstructured":"Heller AJ, Chesterman P, Elwes RDC, et al.: Phenobarbitone, phenytoin, carbamazepine, and sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995, 58:44\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.57.6.682","volume":"57","author":"A Richens","year":"1994","unstructured":"Richens A, Davidson DL, Cartlidge NE, et al.: A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. J Neurol Neurosurg Psychiatry 1994, 57:682\u2013687.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22_CR29","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.33.11.1474","volume":"33","author":"BJ Wilder","year":"1983","unstructured":"Wilder BJ, Ramsay RE, Murphy JV, et al.: Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures. Neurology 1983, 33:1474\u20131476.","journal-title":"Neurology"},{"key":"22_CR30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","volume":"329","author":"JIT Isoj\u00e4rvi","year":"1993","unstructured":"Isoj\u00e4rvi JIT, Laatikainen TJ, Pakarinen AJ, et al.: Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993, 329:1383\u20131388.","journal-title":"N Engl J Med"},{"key":"22_CR31","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1212\/WNL.46.6.1684","volume":"46","author":"E Faught","year":"1996","unstructured":"Faught E, Wilder BJ, Ramsay RE, et al.: Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily doses. Neurology 1996, 46:1684\u20131690.","journal-title":"Neurology"},{"key":"22_CR32","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.43.11.2292","volume":"43","author":"The US Gabapentin Study Group No. 5","year":"1993","unstructured":"The US Gabapentin Study Group No. 5: Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo controlled, parallel-group study. Neurology 1993, 43:2292\u20132298.","journal-title":"Neurology"},{"key":"22_CR33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1528-1157.1998.tb01357.x","volume":"39","author":"A Beydoun","year":"1998","unstructured":"Beydoun A, Fakhoury T, Nasreddine W, et al.: Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Epilepsia 1998, 39:188\u2013193.","journal-title":"Epilepsia"},{"issue":"suppl 3","key":"22_CR34","first-page":"77","volume":"33","author":"AJ Wilensky","year":"1992","unstructured":"Wilensky AJ, Temkin NR, Ojemann LM, et al.: Gabapentin and carbamazepine as monotherapy and combined: a pilot study. Epilepsia 1992, 33(suppl 3):77.","journal-title":"Epilepsia"},{"issue":"suppl 3","key":"22_CR35","first-page":"148","volume":"36","author":"S Schachter","year":"1995","unstructured":"Schachter S, Biton V, Boellner V, et al.: Safety and efficacy of tiagabine HCl monotherapy in the treatment of partial seizures: high dose versus low dose. Epilepsia 1995, 36(suppl 3):148.","journal-title":"Epilepsia"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.47.3.235","volume":"47","author":"NM Milligan","year":"1984","unstructured":"Milligan NM, Dhillon S, Griffiths A, et al.: A clinical trial of single dose rectal and oral administration of diazepam for prevention of serial seizures in adult epileptic patients. J Neurol Neurosurg Psychiatry 1984, 47:235\u2013240.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199806253382602","volume":"338","author":"FE Dreifuss","year":"1998","unstructured":"Dreifuss FE, Rosman NP, Cloyd JC, et al.: A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 1998, 338:1869\u20131875.","journal-title":"N Engl J Med"},{"key":"22_CR38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1345\/aph.17306","volume":"33","author":"MS Akinbi","year":"1999","unstructured":"Akinbi MS, Welty TE: Benzodiazepines in the home treatment of acute seizures. Ann Pharmacother 1999, 33:99\u2013102.","journal-title":"Ann Pharmacother"},{"key":"22_CR39","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1212\/WNL.41.11.1785","volume":"41","author":"IE Leppik","year":"1991","unstructured":"Leppik IE, Dreifiss FE, Pledger GW, et al.: Felbamate for partial seizures: results of a controlled clinical trial. Neurology 1991, 41:1785\u20131789.","journal-title":"Neurology"},{"key":"22_CR40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1528-1157.1991.tb04668.x","volume":"32","author":"WH Theodore","year":"1991","unstructured":"Theodore WH, Raubertas RF, Porter RJ, et al.: Felbamate: a clinical trial for complex partial seizures. Epilepsia 1991, 32:392\u2013397.","journal-title":"Epilepsia"},{"key":"22_CR41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/WNL.51.1.48","volume":"51","author":"A Handforth","year":"1998","unstructured":"Handforth A, DeGiorgio CM, Schachter SC, et al.: Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998, 51:48\u201355.","journal-title":"Neurology"},{"key":"22_CR42","first-page":"137","volume-title":"Surgical Treatment of the Epilepsies","author":"HO L\u00fcders","year":"1993","unstructured":"L\u00fcders HO, Engel J, Munari C: General principles. In Surgical Treatment of the Epilepsies, edn 2. Edited by Engel J. New York: Raven Press; 1993:137\u2013153. This chapter, in a comprehensive textbook of epilepsy surgery, reviews the overall principles for choosing appropriate candidates for surgery.","edition":"edn 2"},{"key":"22_CR43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410400314","volume":"40","author":"F Arruda","year":"1996","unstructured":"Arruda F, Cendes F, Andermann F, et al.: Mesial atrophy and outcome after amygdalohippocampectomy or temporal lobe removal. Ann Neurol 1996, 40:446\u2013450.","journal-title":"Ann Neurol"},{"key":"22_CR44","first-page":"319","volume-title":"Surgical Treatment of the Epilepsies","author":"J Engel","year":"1993","unstructured":"Engel J, Ojemann GA: The next step. In Surgical Treatment of the Epilepsies, edn 2. Edited by Engel J. New York: Raven Press; 1993:319\u2013329.","edition":"edn 2"},{"key":"22_CR45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3171\/jns.1997.87.1.0020","volume":"87","author":"JT King","year":"1997","unstructured":"King JT, Sperling MR, Justice AC, et al.: A costeffectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. J Neurosurg 1997, 87:20\u201322.","journal-title":"J Neurosurg"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-999-0022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-999-0022-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-999-0022-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:05:26Z","timestamp":1559423126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-999-0022-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11940-999-0022-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10]]}}}